Table 1.
Specific baseline clinical characteristic of 1,076 breast cancer patients.
| 1,076 breast cancer patients | |
|---|---|
| Age | |
| <60 years | 572 |
| ≥60 years | 504 |
| Stage | |
| I | 180 |
| II | 610 |
| III | 244 |
| IV | 19 |
| Unknown | 23 |
| Pathologic T stage | |
| T1-2 | 897 |
| T3-4 | 176 |
| Unknown | 3 |
| Pathologic N stage | |
| N0-1 | 862 |
| N2-3 | 194 |
| Unknown | 20 |
| Pathologic M stage | |
| M0 | 896 |
| M1 | 21 |
| Unknown | 159 |
| Estrogen receptor | |
| Positive | 790 |
| Negative | 237 |
| Unknown | 49 |
| Progesterone receptor | |
| Positive | 683 |
| Negative | 341 |
| Unknown | 52 |
| HER2 | |
| Positive | 161 |
| Negative | 554 |
| Unknown | 361 |
| Survival time | |
| ≤ 1 years | 185 |
| 1 years < | 482 |
| ≤ 3 years | |
| 3 years < | 167 |
| ≤ 5 years | |
| >5 years | 242 |